Hasil Pencarian - David T. Dicker
- Menampilkan 1 - 10 hasil dari 10
-
1
Noninvasive vascular imaging in fluorescent tumors using multispectral unmixing oleh Patrick A. Mayes, David T. Dicker, Yingqiu Y. Liu, Wafik S. El-Deiry
Diterbitkan 2008-10-01
Artikel -
2
-
3
Anti-cancer efficacy including Rb-deficient tumors and VHL-independent HIF1α proteasomal destabilization by dual targeting of CDK1 or CDK4/6 and HSP90 oleh Shuai Zhao, Lanlan Zhou, David T. Dicker, Avital Lev, Shengliang Zhang, Eric Ross, Wafik S. El-Deiry
Diterbitkan 2021-10-01
Artikel -
4
P53-independent partial restoration of the p53 pathway in tumors with mutated p53 through ATF4 transcriptional modulation by ERK1/2 and CDK9 oleh Xiaobing Tian, Nagib Ahsan, Amriti Lulla, Avital Lev, Philip Abbosh, David T. Dicker, Shengliang Zhang, Wafik S. El-Deiry
Diterbitkan 2021-03-01
Artikel -
5
Correction: Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway oleh Joshua E Allen, Gabriel Krigsfeld, Luv Patel, Patrick A Mayes, David T Dicker, Gen Sheng Wu, Wafik S El-Deiry
Diterbitkan 2024-10-01
Artikel -
6
-
7
-
8
Sorafenib sensitizes solid tumors to Apo2L/TRAIL and Apo2L/TRAIL receptor agonist antibodies by the Jak2-Stat3-Mcl1 axis. oleh Junaid Abdulghani, Joshua E Allen, David T Dicker, Yingqiu Yvette Liu, David Goldenberg, Charles D Smith, Robin Humphreys, Wafik S El-Deiry
Diterbitkan 2013-01-01
Artikel -
9
A subset of CB002 xanthine analogs bypass p53-signaling to restore a p53 transcriptome and target an S-phase cell cycle checkpoint in tumors with mutated-p53 oleh Liz Hernandez Borrero, David T Dicker, John Santiago, Jennifer Sanders, Xiaobing Tian, Nagib Ahsan, Avital Lev, Lanlan Zhou, Wafik S El-Deiry
Diterbitkan 2021-07-01
Artikel -
10